CLINICAL_TRIALS
trial_result
· 2014-09-26
Clinical Trial Update: Effects of CYP2B6 Genetic Polymorphisms on Efavirenz Pharmacokinetics [NA]
Summary
This clinical trial update reports on how CYP2B6 genetic polymorphisms affect the pharmacokinetics of efavirenz in HIV patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Indiana University | Conditions: HIV | NA | Status: COMPLETED | Results posted: 2014-09-26